ARTreat

ARTreat targets at providing a patient-specific computational model of the cardiovascular system, used to improve the quality of prediction for the atherosclerosis progression and propagation into life-threatening events that need to be treated accordingly.

ARTreat will provide a three-level patient model describing the 3d arterial tree anatomy, the patient-specific blood flow and blood particle dynamics and the biological processes that lead to the creation and progression of atherosclerotic plaques.

ARTreat will apply the developed patient-specific model on two main applications: the clinical decision support and the training. ARTreat will produce two decision support tools to assist clinical cardiologists into providing personalized treatment selection and real-time, on- the-fly advice during invasive interventions, such stent positioning. The aim is to minimize future therapy costs, by providing higher than even possible personalized treatment support. The same patient-specific model will also be used to develop a real-case simulator training, which will support realistic hands-on skill development training to clinical cardiologists.

Finally, ARTreat is coupled with advanced clinical support tools for plaque characterization, and the discovery of new knowledge; associations among heterogeneous data, that can improve the predictive power of the patient-model. It thus supports the medical expert into programming the accumulated knowledge into the existing model and generating an adaptive patient-specific computational tool. Key market players AGFA and SORIN will exploit the ARTreat applications to provide new sophisticated solutions to their product range, while all academic and IT company partners will accumulate significant experience on the new generation patient-specific healthcare services.

For further information, please visit:
http://www.artreat.org

Project co-ordinator:
SWORD TECHNOLOGIES SA

Partners:

  • UNIVERZITET U KRAGUJEVCU
  • COMPUTER SHARING BUCURESTI SRL
  • TECHNOLOGICA EOOD
  • SAS SOFTWARE LIMITED
  • LANZA & THOMPSON INFORMATION TECHNOLOGY SRL
  • TECMIC-TECNOLOGIAS DE MICROELECTRONICA SA
  • FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS
  • THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
  • ADVANCED SIMULATION AND DESIGN GMBH
  • UNIVERSITE PARIS DESCARTES
  • INTERCON SP. Z O.O.
  • EURO (PMS) LIMITED
  • SORIN BIOMEDICA CARDIO S.R.L.
  • AGFA HEALTHCARE N.V.
  • WORLD MATCH LIMITED
  • D.D. SYNERGY HELLAS ANONYMI EMPORIKI ETAIREIA PAROCHIS YPIRESION PLIROFORIKIS
  • CONSIGLIO NAZIONALE DELLE RICERCHE
  • UNIVERSITA DEGLI STUDI DI PARMA

Timetable: from 09/2008 –to 08/2011

Total cost: 10.520.000

EC funding: €7.650.000

Programme Acronym: FP7-ICT

Subprogramme Area: ICT-2007.5.3 Virtual physiological human

Contract type: Collaborative project (generic)

Related news article:

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...